# Clinical Study of HRS-2129 for Acute Gouty Arthritis

> **NCT07706777** · PHASE2 · RECRUITING · sponsor: **Shandong Suncadia Medicine Co., Ltd.** · enrollment: 90 (estimated)

## Conditions studied

- Acute Gouty Arthritis

## Interventions

- **DRUG:** HRS-2129 Tablet
- **DRUG:** HRS-2129 Tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07706777
- **Lead sponsor:** Shandong Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-19
- **Primary completion:** 2026-10
- **Final completion:** 2026-11
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07706777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07706777, "Clinical Study of HRS-2129 for Acute Gouty Arthritis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07706777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*